Clinical Trials Logo

Clinical Trial Summary

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Neuropathic Pain


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00214955
Study type Interventional
Source Teva Pharmaceutical Industries
Contact
Status Completed
Phase Phase 3
Start date September 2005

See also
  Status Clinical Trial Phase
Withdrawn NCT03259451 - Effectiveness of Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Neuropathic Pain
Enrolling by invitation NCT01437332 - Molecular Mediators of Nerve Injury Signaling N/A
Terminated NCT00189059 - Effects of Amitriptyline for the Treatment of Pain on Driving Performance and Cognition. Phase 4
Terminated NCT02335489 - A Post Market Cohort to Assess the Performance of the Spinal Modulation Neurostimulator System for the Management of Chronic Neuropathic Pain of the Foot and/or Lower Leg
Recruiting NCT04936646 - Study of rTMS Analgesic Effect in Chronic Neuropathic Pain, N/A
Terminated NCT01205516 - Methadone in Neuropathic Pain Phase 4
Terminated NCT04287075 - Surgical Treatment of Chronic Neuropathic Pain
Recruiting NCT05537935 - Low Dose Naltrexone for Pain in Patients With HIV Phase 4
Recruiting NCT05593237 - Transcranial Magnetic Stimulation for Chronic Neuropathic Pain N/A
Terminated NCT00189072 - Effects of Gabapentin in the Treatment of Neuropathic Pain on Driving Performance and Cognition Phase 4